Cyp3a Inducers + Darunavir Cobicistat Emtricitabine And Tenofovir Alafenamide Interaction
Moderateinteraction on record
Description
Co-administration may increase clearance of darunavir and cobicistat, resulting in lowered plasma concentrations and potential loss of therapeutic effect and development of resistance.
Mechanism
Increased metabolism of darunavir and cobicistat by CYP3A
Source: NLP:darunavir, cobicistat, emtricitabine, and tenofovir alafenamide